Copper deficiency myelopathy is a spinal cord problem caused by low copper levels. It can lead to numbness, tingling, and trouble walking, and doctors may see weakness and balance loss. Many people with copper deficiency myelopathy also have anemia or low white blood cells. It usually affects adults and can be long‑lasting, but treatment with copper can stop it from getting worse. Mortality is low, and care focuses on copper supplements and treating causes like excess zinc or poor absorption.
Overview
Copper deficiency myelopathySymptoms
Early symptoms of copper deficiency myelopathy include numbness or tingling in the feet, unsteady walking, and trouble with balance. As it progresses, people may notice leg weakness or stiffness, falls, burning sensations, and sometimes bladder problems or fatigue.
Outlook and prognosis
Most people with Copper deficiency myelopathy improve once copper is replaced, especially if treatment starts early. Numbness, gait unsteadiness, and fatigue may ease over months, though recovery can be partial. Ongoing supplements and monitoring help prevent relapse and further nerve damage.
Causes and risk factors
Copper deficiency myelopathy usually stems from low copper due to malabsorption (after gastric bypass or celiac disease), excess zinc from supplements, or long-term diets/IV nutrition lacking copper. Risk rises with bowel disease, diarrhea, and rare inherited copper‑transport disorders.
Genetic influences
Genetics play a minor role in copper deficiency myelopathy. Most cases stem from low copper intake, poor absorption after gastric surgery, excess zinc, or gastrointestinal disease. Rarely, inherited disorders of copper transport or metabolism can increase vulnerability.
Diagnosis
Doctors diagnose Copper deficiency myelopathy using neurologic exam findings plus blood tests showing low copper and low ceruloplasmin. Spinal MRI and checks for vitamin B12 deficiency and excess zinc help confirm the diagnosis of Copper deficiency myelopathy and exclude mimics.
Treatment and drugs
Treatment for copper deficiency myelopathy focuses on restoring copper levels and protecting the spinal cord. Most people receive oral copper supplements; some start with short-term intravenous copper if levels are very low or symptoms progress quickly. Doctors also address triggers, like excess zinc or malabsorption, and support recovery with physical therapy.
Symptoms
In everyday life, walking may feel less steady, with numb, heavy feet and more trips or near-falls on uneven ground. Early symptoms of copper deficiency myelopathy often include tingling in the feet, trouble with balance that’s worse in the dark, and leg stiffness that makes stairs or long walks harder. Symptoms vary from person to person and can change over time. Family or friends may notice a change in your gait or posture.
You may feel unsure on your feet, with a wider or cautious gait. Curbs, crowds, and uneven ground become harder to navigate. Falls or near-falls may happen more often.
Pins-and-needles often start in the toes and feet, sometimes moving up the legs. Hands can be affected later. This often makes it harder to feel the ground under your feet.
Muscles in the legs can feel tight or crampy. Steps may feel jerky, and quick changes in direction are tougher. Some notice the legs are hard to relax after walking.
Without visual cues, it’s harder to tell where your feet are. Walking on dim stairways or in a dark bedroom may feel unsafe. This is typical in copper deficiency myelopathy.
How people usually first notice Copper deficiency myelopathy?
People often first notice copper deficiency myelopathy through subtle changes in walking—legs may feel heavy or unsteady, with a tendency to trip or a “spongy” numbness in the feet that creeps upward. Over weeks to months, this can progress to tingling, reduced vibration sense, or a band-like tightness around the torso; some also develop weakness or increased muscle tone and brisk reflexes that feel like their legs won’t “listen.” Doctors are often alerted by a combination of gait imbalance, sensory loss in a stocking pattern, and signs of spinal cord involvement on exam, especially in people with risk factors like prior gastric bypass, long-term zinc supplements, or malabsorption.
Types of Copper deficiency myelopathy
Copper deficiency myelopathy affects the spinal cord and can show up in different, recognizable ways. Some people notice mostly walking and balance problems; others feel more numbness, pins-and-needles, or fatigue. Symptoms don’t always look the same for everyone. When people talk about types of copper deficiency myelopathy, they usually mean patterns of symptoms rather than separate diseases.
Gait and balance
Trouble walking on uneven ground and frequent stumbles are common. Legs can feel heavy or stiff, and vibration sense in the feet may be reduced. Falls may increase, especially in low light.
Sensory-predominant
Numbness, tingling, or a band-like tightness can spread from the feet upward. Fine touch and position sense often fade first, making it hard to know where the feet are. Pain can be mild or absent despite significant numbness.
Spasticity-dominant
Leg muscles feel tight with cramping, and knees may “catch” or scissor during steps. Reflexes are brisk, and foot tapping becomes slower or jerky. Stiffness can worsen after sitting and ease slightly with slow stretching.
Posterior column signs
Loss of vibration and joint-position sense stands out on exam. People may stomp their feet to feel the ground or need railings on stairs. Uneven surfaces and eyes-closed standing make imbalance more obvious.
Peripheral nerve overlap
Weakness and numbness also involve the hands and feet like a glove-and-stocking pattern. Pins-and-needles and reduced ankle reflexes can point to a mixed nerve and spinal cord picture. This overlap can blur the early symptoms of copper deficiency myelopathy.
Mild, early stage
Subtle foot numbness, fatigue with long walks, or occasional toe catching may be the only clues. Symptoms can fluctuate day to day, which delays recognition. Early symptoms of copper deficiency myelopathy may improve more with timely copper replacement.
Advanced, progressive
Walking aids become necessary as stiffness and numbness spread. Bladder urgency or constipation can appear, and fine foot placement becomes difficult. Recovery is more limited at this stage even after copper levels are corrected.
What genetics can tell you about symptoms
Some people with variants in genes that handle copper transport, such as ATP7A, develop spinal cord damage sooner and at lower copper levels, leading to numbness, tingling, or weakness in the legs. These changes can also cause trouble walking, balance problems, and a stiff, spastic gait.
Causes and risk factors
Copper deficiency myelopathy can develop when copper stays low for a long time and injures the spinal cord. Risk is higher after gastric bypass or other stomach or bowel surgery, with gut diseases that reduce absorption, and with rare genetic problems that affect copper handling. Too much zinc from supplements or denture creams can block copper, and very low copper intake can add to the risk. People worried about early symptoms of Copper deficiency myelopathy often have one or more of these risks. Doctors distinguish between risk factors you can change and those you can’t.
Environmental and biological risk factors
Copper deficiency myelopathy affects the spinal cord and can cause numbness, tingling, unsteady walking, and weakness that build slowly. Knowing what raises risk helps you act early if early symptoms of copper deficiency myelopathy start to appear. Doctors often group risks into internal (biological) and external (environmental). Below are key factors that can lower copper levels and raise the chance of this condition.
Rerouting food away from the upper small intestine reduces copper absorption. This raises long-term risk of copper deficiency myelopathy. Problems can appear years after surgery.
Removing parts of the duodenum or nearby small intestine limits where copper is taken up. The shorter length increases the chance of deficiency over time. Larger resections carry higher risk.
Diseases that injure the small-intestine lining, such as celiac disease or Crohn’s, block copper uptake. Ongoing inflammation or untreated disease can deplete stores and lead to copper deficiency myelopathy. Flare-ups are periods of higher risk.
High zinc from cold lozenges or supplements makes the gut trap and waste copper. Over months, this can trigger copper deficiency myelopathy. Using multiple zinc sources at once raises the risk.
Genetic risk factors
Genetics can, in rare cases, set the stage for copper levels to fall low enough to affect the spinal cord. Copper deficiency myelopathy is most often acquired, but a handful of inherited conditions can increase risk by disrupting copper transport or gut absorption. Carrying a genetic change doesn’t guarantee the condition will appear. Understanding these links can help you act sooner if early symptoms of copper deficiency myelopathy show up.
ATP7A-related disorders: Inherited changes in the ATP7A gene (the Menkes spectrum, including occipital horn syndrome) reduce the body’s ability to move copper where it’s needed. These X-linked conditions mainly affect males and can harm the nervous system, sometimes producing a spinal cord picture similar to copper deficiency myelopathy. Female carriers are usually well but can occasionally have mild features.
CTR1 gene variants: Very rare mutations in SLC31A1 (also called CTR1), the main copper uptake transporter, limit how much copper is absorbed from food. Reported cases show low copper from early life with neurologic problems, underscoring that impaired uptake alone can set up deficiency-related nerve injury.
Celiac risk genes: Specific HLA types (DQ2 or DQ8) raise the chance of celiac disease, which can damage the small intestine and reduce mineral absorption. When celiac disease occurs, the resulting malabsorption can lower copper levels and, in some adults, contribute to copper deficiency myelopathy.
Family history: Having close relatives with ATP7A-related conditions or rare copper transporter defects signals an inherited susceptibility. A genetics professional can review your family tree, discuss testing options, and tailor a plan for monitoring copper status.
Lifestyle risk factors
Certain habits can lower copper levels or block its absorption, increasing the chance of spinal cord damage from copper deficiency myelopathy. Diet and supplement choices are the main lifestyle risk factors for copper deficiency myelopathy. Paying attention to how lifestyle affects copper deficiency myelopathy can help with prevention and recovery along with medical care.
Diets that chronically lack copper-rich foods can deplete body stores. Skipping foods like shellfish, organ meats, nuts, seeds, legumes, and whole grains raises risk.
High zinc intake blocks intestinal copper absorption through shared transporters. Frequent use of zinc lozenges, high-dose multivitamins, or zinc-containing denture creams can trigger copper deficiency myelopathy.
Large or prolonged iron supplementation competes with copper and may reduce its absorption. Taking high-dose iron without monitoring can worsen or precipitate neurologic symptoms in copper deficiency myelopathy.
Diets heavy in bran, unrefined grains, or phytate-rich fiber supplements can bind copper and lower its bioavailability. When combined with low copper intake, this pattern increases risk of copper deficiency myelopathy.
Risk prevention
Copper deficiency myelopathy can often be prevented by keeping copper intake steady and avoiding things that block its absorption. People most at risk include those with high zinc intake, a history of weight-loss (bariatric) surgery, or conditions that limit nutrient absorption. Prevention is about lowering risk, not eliminating it completely. If you’re in a higher-risk group, targeted supplements and regular lab checks can catch problems early.
Aim for about 900 micrograms (0.9 mg) of copper daily from food or supplements. Good sources include shellfish, nuts, seeds, beans, whole grains, and organ meats.
High-dose zinc (for example, more than 40 mg/day) can block copper absorption. Check cold lozenges, denture creams, and multivitamins for zinc load and discuss safe dosing if you need zinc.
After bariatric surgery, ask for copper and ceruloplasmin blood tests every 6–12 months. Many will need lifelong supplementation to prevent deficiency-related nerve and spinal cord problems.
If you take zinc, choose a multivitamin that also contains copper (often 1–2 mg) to keep a healthy balance. A typical zinc-to-copper ratio of roughly 8–15:1 helps lower deficiency risk.
Transmission
Copper deficiency myelopathy is not contagious—you can’t catch it or pass it on through touch, coughing, kissing, sex, blood contact, or breastfeeding. It develops when the body’s copper level is too low, most often after stomach or intestinal surgery (including weight-loss procedures), from too much zinc in supplements or denture creams, or from very poor intake over time. There is no person-to-person transmission of Copper deficiency myelopathy, and it is not inherited; having a family member with it doesn’t raise your risk unless you share the same exposures or surgeries. In other words, there is no genetic transmission of Copper deficiency myelopathy; prevention centers on keeping copper intake adequate and avoiding excess zinc with your clinician’s guidance.
When to test your genes
Consider genetic testing if you developed copper deficiency myelopathy without an obvious cause (like bariatric surgery, excess zinc, or malabsorption), especially with a family history of unexplained neuropathy or anemia. Testing can uncover inherited factors affecting copper transport or absorption that guide targeted treatment and monitoring. Ask your clinician or a genetic counselor to tailor the panel.
Diagnosis
People with copper deficiency myelopathy often notice tingling in the feet, trouble with balance, or a heavy, tired feeling in the legs that creeps up over time. These changes usually lead to a clinic visit, where your provider pieces together symptoms, exam findings, and tests. Doctors usually begin with a careful history and physical exam, then use targeted blood tests and scans to confirm the cause. The goal is to identify the deficiency and any trigger—like excess zinc or a gut issue—so treatment can start promptly.
Your provider asks about symptoms, diet, supplements, and past surgeries, especially stomach or weight-loss procedures. Details about denture creams, multivitamins, or zinc products can be key.
The exam checks walking, balance, reflexes, and vibration sense in the feet and legs. Patterns suggesting spinal cord pathways are affected raise concern for copper deficiency myelopathy.
A blood test measures copper levels, which are usually low in this condition. These results often anchor the diagnosis of copper deficiency myelopathy.
Blood zinc is checked because high zinc can block copper absorption. If zinc is elevated, stopping the source becomes part of treatment planning.
Stages of Copper deficiency myelopathy
Copper deficiency myelopathy does not have defined progression stages. Symptoms can build gradually or progress more quickly depending on how low copper levels are and for how long, so there isn’t a predictable step-by-step pattern. Early symptoms of copper deficiency myelopathy can include tingling, numbness, and a shaky or unsteady walk, which are sometimes mistaken for vitamin B12–related issues. Different tests may be suggested to help confirm the cause, such as blood tests for copper and zinc, checks for anemia, and an MRI of the spinal cord; doctors also look for possible triggers like prior stomach surgery, too much zinc from supplements or denture creams, or gut absorption problems, and then monitor recovery with repeat labs and neurological exams.
Outlook and prognosis
Day to day, copper deficiency myelopathy can affect balance, walking, and the fine control needed for tasks like buttoning a shirt or typing. Many people ask, “What does this mean for my future?”, and the answer depends on how quickly the low copper is found and treated. Early care can make a real difference, especially if treatment starts soon after early symptoms of copper deficiency myelopathy such as numbness in the feet, unsteady gait, or tiredness from anemia appear.
Understanding the prognosis can guide planning and expectations. Once copper levels are corrected—usually with supplements and addressing the cause—many people stabilize, and some regain function over months. Nerve pathways in the spinal cord heal slowly, so improvements are often gradual and may plateau. If diagnosis is delayed, some walking or sensation changes can be long‑lasting. Mortality from copper deficiency myelopathy itself is uncommon; serious risks usually come from complications like falls, severe anemia, or the underlying reason for the deficiency (for example, excess zinc intake or prior stomach surgery).
Looking at the long-term picture can be helpful. With ongoing care, many people maintain independence, drive, and work, sometimes using a cane or therapy to adapt. Regular follow‑up blood tests help keep copper and zinc in balance and reduce the chance of relapse. Talk with your doctor about what your personal outlook might look like, including how fast symptoms changed, your lab results, and any other health conditions that might influence recovery.
Long-term effects
Over time, copper deficiency myelopathy can lead to lasting changes in movement and sensation, even after copper levels are corrected. Long-term effects vary widely. Treatment often stops further worsening, but recovery is usually slow and may be incomplete. Some people are left with numbness or gait imbalance that affects daily activities, like walking on uneven ground or climbing stairs.
Ongoing unsteadiness and a wide-based walk can persist. Many people find uneven surfaces or dim lighting make balance tougher. Falls risk can remain higher than average.
Tingling and numbness in the feet and hands may linger. Early symptoms of copper deficiency myelopathy often include numbness in the toes that slowly climbs up the legs. Fine touch and vibration sense can stay dulled.
Muscles, especially in the legs, can feel stiff or tight. This may cause scissoring steps or leg cramps. Spasticity can make walking slower and more effortful.
Weakness in the lower limbs can persist even after treatment. Stairs and long walks may stay challenging. Fatigue can show up sooner with activity.
How is it to live with Copper deficiency myelopathy?
Living with copper deficiency myelopathy often means dealing with a gradual, frustrating mix of numbness, tingling, and a heavy, unsteady feeling in the legs that can turn simple walks or stair-climbing into careful, deliberate efforts. Many notice balance problems, fatigue, and reduced hand dexterity that slow daily tasks at home and at work, and some need a cane or walker during flares or while recovering. With treatment and nutrition changes, symptoms may stabilize or partially improve, but progress can be slow, and people sometimes adapt by planning rest, using mobility aids, and arranging spaces to reduce fall risk. Family, friends, and coworkers often become part of the support system—offering rides, patience with pace, and help with fine-motor chores—which can strengthen relationships when communication is open about needs and limits.
Treatment and drugs
Treatment for copper deficiency myelopathy focuses on restoring copper levels and protecting the spinal cord from further damage. Most people start with copper supplements by mouth; if levels are very low or symptoms are worsening, doctors may begin with intravenous copper in the hospital and then switch to tablets. Your doctor may also reduce or stop things that block copper absorption, such as excess zinc supplements, certain stomach-acid medicines, or poorly balanced bariatric surgery diets. Supportive care can make a real difference in how you feel day to day, including physical and occupational therapy to improve balance, walking, and hand coordination, plus treatment of anemia if present. Early treatment can stop the condition from getting worse, and some symptoms improve over months, though nerve recovery can be slow and may not be complete.
Non-drug treatment
Copper deficiency myelopathy can affect walking, balance, hand use, and day‑to‑day independence. Alongside medicines, non-drug therapies can strengthen your recovery and help prevent avoidable setbacks. The focus is on rebuilding skills, protecting safety, and adapting routines at home and work. Starting rehab when early symptoms of copper deficiency myelopathy appear may help you keep function while medical treatment takes effect.
Targeted exercises build strength, stability, and endurance for safer walking. Therapists tailor programs to your goals and any nerve or spinal cord changes. Progress is paced to avoid overexertion.
Step‑pattern drills and balance practice reduce falls and improve confidence. Visual and auditory cues can compensate for reduced joint position sense. Treadmill or harness systems may be used in clinic.
Daily‑task retraining makes dressing, cooking, and work easier and safer. Therapists suggest simpler movement patterns and energy‑saving strategies. Home and workplace adaptations are planned together.
Canes, trekking poles, or walkers add stability and reduce fall risk. An ankle‑foot orthosis can steady a weak or uncoordinated foot. Your device is fitted and adjusted as your gait improves.
Your genes may have an impact on how drugs work for you
Medications used alongside copper replacement can be shaped by your genes—for example, differences in drug-processing enzymes may change how you respond to neuropathic pain treatments or acid-reducing drugs that affect mineral absorption. Pharmacogenetic testing sometimes guides safer dosing and fewer side effects.
Pharmacological treatments
Treatment focuses on replacing copper to halt further nerve damage and support recovery, especially when early symptoms of copper deficiency myelopathy are recognized. Severe deficiency may start with intravenous therapy and then move to daily tablets, while milder cases often use oral copper alone. Drugs that target symptoms directly are called symptomatic treatments. These can help with pain and muscle stiffness while copper levels are brought back to normal.
Copper gluconate or copper sulfate tablets are used to rebuild low copper stores. Doctors typically adjust the dose based on blood levels and how you feel.
Cupric chloride given by IV can be used first if deficiency is severe or absorption is poor. People are usually transitioned to oral copper once levels stabilize.
Gabapentin, pregabalin, or duloxetine can ease burning, tingling, or electric-shock–like pain. These medicines help symptoms while copper repletion addresses the root problem.
Baclofen or tizanidine may reduce muscle stiffness and spasms that affect walking and balance. Doses are increased slowly to reach benefit with fewer side effects.
Genetic influences
Most cases of copper deficiency myelopathy are not caused by inherited gene changes. It’s natural to ask whether family history plays a role. In adults, this condition usually arises from non-genetic factors that lower copper levels—such as reduced absorption after stomach or bowel surgery, long-term zinc use, or gut conditions—rather than from a trait passed down in families. Rare inherited disorders that disrupt copper handling, including the Menkes spectrum, can cause low copper and neurological problems, but they typically begin in infancy or childhood and don’t match the usual adult pattern of copper deficiency myelopathy. Wilson disease is a different genetic disorder that leads to copper buildup; while its treatment with zinc can lower copper, the disease itself does not cause the deficiency seen in copper deficiency myelopathy. If early symptoms of copper deficiency myelopathy make you wonder about heredity, a genetics professional can review your family history and advise whether any testing is worthwhile; for most adults with this diagnosis, no genetic cause is found.
Is Copper deficiency myelopathy genetic?
Genetics play a minor role in copper deficiency myelopathy. Most cases stem from low copper intake, poor absorption after gastric surgery, excess zinc, or gastrointestinal disease. Rarely, inherited disorders of copper transport or metabolism can increase vulnerability.
Pharmacogenetics—how genetics influence drug effects
Treatment for Copper deficiency myelopathy centers on replacing copper and removing triggers like excess zinc, and care is usually guided by blood tests and how well the stomach and bowel can absorb copper rather than by genetics. Not every difference in response is genetic, but rare inherited problems with copper transport can change how the body absorbs, uses, or loses copper, so a genetics referral may be considered if the story is unusual or there’s a notable family history. There are no established pharmacogenetic dosing guidelines for copper supplements or for medicines sometimes used alongside treatment. In practice, dose adjustments are based on follow-up lab results and symptoms, not a specific gene test. If an inherited copper disorder is found, specialists may tailor care, yet correcting low copper still relies on careful replacement and avoiding competing minerals like zinc. Let your doctor know about all medicines and supplements you take, because some can interfere with copper absorption even when genetics do not.
Interactions with other conditions
Copper deficiency myelopathy often shows up or worsens in settings that limit nutrient absorption, such as celiac disease, inflammatory bowel disease, or after bariatric and other stomach surgeries. Too much zinc—from supplements, lozenges, or some denture creams—blocks copper uptake and can trigger or aggravate Copper deficiency myelopathy. Many people develop anemia and low white blood cells alongside this condition, so fatigue and infection risk from those blood changes can add to the walking and balance problems. Early symptoms of Copper deficiency myelopathy can overlap with vitamin B12 deficiency or multiple sclerosis, and when B12 lack occurs at the same time, nerve damage can progress unless both nutrients are corrected. Talk with your doctor about how your conditions may influence each other. Ongoing conditions that affect the gut, long-term zinc use, or combined nutrient shortages may each play a role, but with coordinated care and copper repletion many people regain stability and prevent further decline.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described unsteady walking, numb feet, and a heavy, tired feeling in the legs that slowly worsened over months. In some families, relatives recalled elders who shifted from a cane to a walker, not because of joint pain, but because their legs felt “asleep.” These everyday stories mirror what clinicians would later recognize as copper deficiency myelopathy, a spine-related problem linked to low copper levels.
First described in the medical literature as a gradual spinal cord injury resembling vitamin B12 deficiency, it puzzled doctors at first. People had tingling, balance problems, and trouble sensing where their feet were, yet their B12 tests looked fine. From these first observations, patterns emerged: gastric surgery years earlier, long-term zinc use from supplements or denture creams, or conditions that reduced nutrient absorption. When copper was checked—and replaced—many stabilized, and some improved, which helped confirm the connection.
In recent decades, knowledge has built on a long tradition of observation. As lab testing became more accurate, doctors could measure copper and a related protein called ceruloplasmin more reliably. Case series from neurology and hematology clinics showed that the spinal cord findings and specific blood changes often traveled together. Reports also highlighted that people without obvious risk factors could still develop copper deficiency myelopathy, reminding clinicians to keep an open mind when evaluating early symptoms of copper deficiency myelopathy like numbness, clumsy walking, or a band-like tightness around the torso.
Medical classifications changed as specialists recognized how closely this condition can mimic other causes of spinal cord damage. Earlier labels focused on “myeloneuropathy” or B12-like syndromes; over time, naming shifted toward copper deficiency myelopathy, placing the nutrient cause at the center. This shift mattered, because it prompted routine copper testing in the right clinical settings and encouraged early treatment to prevent further nerve injury.
Advances in nutrition science and gastroenterology added more pieces. Clinicians learned that too much zinc can block copper absorption, and that certain surgeries, inflammatory bowel disease, and severe dietary restriction could tip the body into deficiency. Radiology contributed by showing subtle changes in the back part of the spinal cord on MRI, supporting the diagnosis when blood tests and symptoms aligned.
Despite evolving definitions, the core lesson has held steady: timely recognition and copper replacement can halt progression for many living with copper deficiency myelopathy. Today’s approach—ask about risk factors, check copper levels, adjust supplements, and replace copper—grew from decades of careful observation and shared clinical experience.